Today's Date
Peanut Oral Immunotherapy in Children
(
IMPACT
)
ITN Protocol #:
ITN050AD
Branded Name:
IMPACT
ClinicalTrials.Gov ID:
NCT01867671Treatment Protocol #:
Therapeutic Area:
Allergy & Asthma
Current Status:
Completed
Summary:
Tolerance Development Following Peanut Oral Immunotherapy in 1-3-Year Old Children 2 with Peanut Allergy: Findings from the Immune Tolerance Network IMPACT Trial
Clinical Operations Associate Director & Manager
ITN Clinical Trial Physician
Rho Scientist
Study Personnel:
